ABAD Directly Links Aß to Mitochondrial Toxicity in Alzheimer's Disease
The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Mitochondrial dysfunction is a hallmark of β-amyloid (Aβ)–induced neuronal toxicity in Alzheimer's disease (AD). Here, we demonstrate that Aβ-binding alcohol dehydrogenase (ABAD) is a direct molecular link from Aβ to mitochondrial toxicity. Aβ interacts with ABAD in the mitochondria of AD patients and transgenic mice. The crystal structure of Aβ-bound ABAD shows substantial deformation of the active site that prevents nicotinamide adenine dinucleotide (NAD) binding. An ABAD peptide specifically inhibits ABAD-Aβ interaction and suppresses Aβ-induced apoptosis and free-radical generation in neurons. Transgenic mice overexpressing ABAD in an Aβ-rich environment manifest exaggerated neuronal oxidative stress and impaired memory. These data suggest that the ABAD-Aβ interaction may be a therapeutic target in AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additionally, Aβ interacts specifically with mitochondrial Aβ-binding alcohol dehydrogenase (ABAD), impeding the binding of NAD to ABAD and inducing ROS production.287,288”
From Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies. (2024) · cites this paper as [287]
In the citing paper
“A number of studies have associated intraneuronal Ab buildup with hyperphosphorylation of tau protein, 8 disturbed protein trafficking and sorting, 9 reduced expression of synaptic proteins, 10 and mitochondrial dysfunction.11,12”
From Blocking the Interaction between Apolipoprotein E and Aβ Reduces Intraneuronal Accumulation of Aβ and Inhibits Synaptic Degeneration (2013) · cites this paper as [11]
In the citing paper
“Aβ, and its precursor APP, localize, in part, to mitochondria in which they can cause mitochondrial dysfunction as evidenced by increased production of RS, enzyme inhibition, loss of cytochrome c, and depolarization of Δψm (Casley et al., 2002a; Kim et al., 2002; Anandatheerthavarada et al., 2003; Jang and Surh, 2003; Lustbader et al., 2004; Liang et al., 2009; Takuma et al., 2009).”
From The mitochondria-targeted antioxidant MitoQ prevents loss of spatial memory retention and early neuropathology in a transgenic mouse model of Alzheimer’s disease (2011) · cites this paper as Lustbader et al., 2004
In the citing paper
“Aβ is reported to increase RS in neurons via multiple mechanisms, including direct Aβ-induced RS production, elevated NADPH oxidase activity, interaction with mitochondria-associated Aβ alcohol dehydrogenase, inhibition of cytochrome oxidase (respiratory complex IV), and by causing leakage of electrons from the mitochondrial electron transport chain (Hensley et al., 1994; Canevari et al., 1999; L”
From The mitochondria-targeted antioxidant MitoQ prevents loss of spatial memory retention and early neuropathology in a transgenic mouse model of Alzheimer’s disease (2011) · cites this paper as Lustbader et al., 2004
In the citing paper
“Intracellular Aβ may then enter the mitochondria in which it induces additional RS and magnifies the metabolic deficit”
From The mitochondria-targeted antioxidant MitoQ prevents loss of spatial memory retention and early neuropathology in a transgenic mouse model of Alzheimer’s disease (2011) · cites this paper as Lustbader et al., 2004
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Mucke, L., Masliah, E., Yu, G.-Q., Mallory, M., Rockenstein, E. M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K., & McConlogue, L. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04050.2000 · Cited by 1,856
Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease
Morgan, D., Diamond, D. M., Gottschall, P. E., Ugen, K. E., Dickey, C., Hardy, J., Duff, K., Jantzen, P., DiCarlo, G., Wilcock, D., et al. (2000) · Nature · doi:10.1038/35050116 · Cited by 1,498
Treatment of Ischemic Brain Damage by Perturbing NMDA Receptor- PSD-95 Protein Interactions
Aarts, M., Liu, Y., Liu, L., Besshoh, S., Arundine, M., Gurd, J. W., Wang, Y.-T., Salter, M. W., & Tymianski, M. (2002) · Science · doi:10.1126/science.1072873 · Cited by 999
Rego, A. C., & Oliveira, C. R. (2003) · Neurochemical Research · doi:10.1023/a:1025682611389 · Cited by 472
TAT-Mediated Protein Transduction into Mammalian Cells
Becker-Hapak, M., McAllister, S. S., & Dowdy, S. F. (2001) · Methods · doi:10.1006/meth.2001.1186 · Cited by 384
Du Yan, S., Fu, J., Soto, C., Chen, X., Zhu, H., Al-Mohanna, F., Collison, K., Zhu, A., Stern, E., Saido, T., et al. (1997) · Nature · doi:10.1038/39522 · Cited by 379
Self-citationRole of mitochondrial dysfunction in Alzheimer's disease
Castellani, R., Hirai, K., Aliev, G., Drew, K. L., Nunomura, A., Takeda, A., Cash, A. D., Obrenovich, M. E., Perry, G., & Smith, M. A. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10389 · Cited by 364
Mitochondria in Alzheimer's disease
Swerdlow, R. H., & Kish, S. J. (2002) · International review of neurobiology · doi:10.1016/s0074-7742(02)53013-0 · Cited by 126
Role of ERAB/l-3-Hydroxyacyl-coenzyme A Dehydrogenase Type II Activity in Aβ-induced Cytotoxicity
Du Yan, S., Shi, Y., Zhu, A., Fu, J., Zhu, H., Zhu, Y., Gibson, L., Stern, E., Collison, K., Al-Mohanna, F., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.4.2145 · Cited by 120
Self-citationGrill, H. P., Zweier, J. L., Kuppusamy, P., Weisfeldt, M. L., & Flaherty, J. T. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90457-x · Cited by 108
Self-citation
Research works printed but not linked: 2
- M. A. Abreoet al. U.S. Patent and Trademark Office serial number 931186 (2002) vol. 9.
- We thank D. Eliezer and T. McGraw for helpful discussions K. D'Amico and L. Tong for help with data collection at the Advanced Photon Source and D. Landry for help with the surface plasmon resonance experiment. This work was supported by P50AG08702 AG16736 AG17490 and NS42855 and in part by Speaker's Fund for Biomedical Research and NIH 1K07AG00959. H.W. is a Pew Scholar of biomedical sciences and a Rita Allen Scholar. The atomic coordinates have been deposited in the Protein Data Bank (PDB accession code 1SO8).
Cited by
Items 501–600 of 1,002
Cytochrome c Oxidase and Its Role in Neurodegeneration and Neuroprotection
Arnold, S. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-3573-0_13 · Cited by 85
Ding, X.-W., Robinson, M., Li, R., Aldhowayan, H., Geetha, T., & Babu, J. R. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105783 · Cited by 88
The necroptosis cell death pathway drives neurodegeneration in Alzheimer’s disease
Balusu, S., & Strooper, B. D. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02747-5 · Cited by 85
Reddy, P. H., & McWeeney, S. K. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.04.014 · Cited by 83
Iijima-Ando, K., Hearn, S. A., Granger, L., Shenton, C., Gatt, A., Chiang, H.-C., Hakker, I., Zhong, Y., & Iijima, K. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710509200 · Cited by 74
Yang, S., He, X., & Miller, D. L. (2007) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2007.06.001 · Cited by 79
Neuroinflammation in Alzheimer’s disease: Pleiotropic roles for cytokines and neuronal pentraxins
Swanson, A., Wolf, T., Sitzmann, A., & Willette, A. A. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.02.015 · Cited by 72
Membrane trafficking in neuronal maintenance and degeneration
Wang, D., Chan, C., Cherry, S., & Hiesinger, P. R. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1201-4 · Cited by 77
Sarkar, P., Zaja, I., Bienengraeber, M., Rarick, K. R., Terashvili, M., Canfield, S., Falck, J. R., & Harder, D. R. (2014) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00001.2013 · Cited by 72
Identification of small-molecule inhibitors of the Aβ–ABAD interaction
Xie, Y., Deng, S., Chen, Z., Yan, S.-D., & Landry, D. W. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.05.099 · Cited by 81
Self-citationDystrophic neurites of senile plaques in Alzheimer’s disease are deficient in cytochrome c oxidase
Pérez-Gracia, E., Torrejón-Escribano, B., & Ferrer, I. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0370-6 · Cited by 81
Calkins, M., Manczak, M., & Reddy, P. (2012) · Pharmaceuticals · doi:10.3390/ph5101103 · Cited by 73
Dhitavat, S., Ortiz, D., Rogers, E. J., Rivera, E. R., & Shea, T. B. (2005) · Brain Research · doi:10.1016/j.brainres.2005.05.074 · Cited by 77
Hroudová, J., Singh, N., Fišar, Z., & Ghosh, K. K. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.03.084 · Cited by 78
Kuruva, C. S., Manczak, M., Yin, X., Ogunmokun, G., Reddy, A. P., & Reddy, P. H. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx226 · Cited by 71
RetractedRahman, M. A., Rahman, M. H., Biswas, P., Hossain, M. S., Islam, R., Hannan, M. A., Uddin, M. J., & Rhim, H. (2020) · Antioxidants · doi:10.3390/antiox10010023 · Cited by 77
Isobe, C., Abe, T., & Terayama, Y. (2009) · Journal of Neurology · doi:10.1007/s00415-009-5333-x · Cited by 79
Mechanisms Linking Mitochondrial Dysfunction and Proteostasis Failure
Lu, B., & Guo, S. (2020) · Trends in Cell Biology · doi:10.1016/j.tcb.2020.01.008 · Cited by 69
Mancuso, M., Orsucci, D., LoGerfo, A., Calsolaro, V., & Siciliano, G. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-6448-9_4 · Cited by 75
Wang, H., Luo, W., Chen, H., Cai, Z., & Xu, G. (2024) · Mitochondrion · doi:10.1016/j.mito.2024.101847 · Cited by 76
Chen, Y., Zheng, H., Huang, X., Han, S., Zhang, D., Ni, J., & He, X. (2015) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12473 · Cited by 71
Peptides as Potential Therapeutics for Alzheimer’s Disease
Ribarič, S. (2018) · Molecules · doi:10.3390/molecules23020283 · Cited by 67
Stepanov, Y. V., Golovynska, I., Zhang, R., Golovynskyi, S., Stepanova, L. I., Gorbach, O. I., Dovbynchuk, T., Garmanchuk, L., Ohulchanskyy, T. Y., & Qu, J. (2022) · Alzheimer s Research & Therapy · doi:10.1186/s13195-022-01022-7 · Cited by 73
Yi, J., Wang, H., Lu, G. X., Zhang, H., Wang, L., Li, Z.-Y., Wang, L., Wu, Y., Xia, D., Fang, E. F., et al. (2024) · Autophagy · doi:10.1080/15548627.2024.2383145 · Cited by 76
Mitochondrial toxins and neurodegenerative diseases
Ayala, A. (2007) · Frontiers in Bioscience · doi:10.2741/2119 · Cited by 68
Han, S.-H., Park, J.-C., & Mook-Jung, I. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.12.004 · Cited by 67
Reassessment of Pioglitazone for Alzheimer’s Disease
Saunders, A. M., Burns, D. K., & Gottschalk, W. K. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.666958 · Cited by 63
Endophilin I Expression Is Increased in the Brains of Alzheimer Disease Patients
Ren, Y., Xu, H. W., Davey, F., Taylor, M., Aiton, J., Coote, P., Fang, F., Yao, J., Chen, D., Chen, J. X., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707932200 · Cited by 66
Self-citationGao, X., & Tang, X. C. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.20791 · Cited by 67
Mitochondrial diacylglycerol initiates protein-kinase-D1-mediated ROS signaling
Cowell, C. F., Döppler, H., Yan, I. K., Hausser, A., Umezawa, Y., & Storz, P. (2009) · Journal of Cell Science · doi:10.1242/jcs.041061 · Cited by 67
Kynurenines, neurodegeneration and Alzheimer’s disease
Kincses, Z. T., Toldi, J., & Vécsei, L. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01123.x · Cited by 68
Alzheimer's Disease: From Mitochondrial Perturbations to Mitochondrial Medicine
Cardoso, S., Carvalho, C., Correia, S. C., Seiça, R. M., & Moreira, P. I. (2016) · Brain Pathology · doi:10.1111/bpa.12402 · Cited by 67
Nakamura, T., & Lipton, S. A. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7916 · Cited by 72
Designed Cell-Penetrating Peptide Inhibitors of Amyloid-beta Aggregation and Cytotoxicity
Henning‐Knechtel, A., Kumar, S., Wallin, C., Król, S. K., Wärmländer, S. K. T. S., Jarvet, J., Esposito, G., Kırmızıaltın, S., Gräslund, A., Hamilton, A. D., et al. (2020) · Cell Reports Physical Science · doi:10.1016/j.xcrp.2020.100014 · Cited by 70
Mortalin overexpression attenuates beta-amyloid-induced neurotoxicity in SH-SY5Y cells
Qu, M., Zhou, Z., Xu, S., Chen, C., Yu, Z., & Wang, D. (2010) · Brain Research · doi:10.1016/j.brainres.2010.10.068 · Cited by 68
The consequences of mitochondrial amyloid β-peptide in Alzheimer's disease
Muirhead, K. E. A., Borger, E., Aitken, L., Conway, S. J., & Gunn, F. J. (2010) · Biochemical Journal · doi:10.1042/bj20091941 · Cited by 82
Self-citationHou, Y., Ghosh, P., Wan, R., Ouyang, X., Cheng, H., Mattson, M. P., & Cheng, A. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.11.002 · Cited by 65
Harnessing neuroplasticity: modern approaches and clinical future
Sasmita, A. O., Kuruvilla, J., & Ling, A. P. K. (2018) · International Journal of Neuroscience · doi:10.1080/00207454.2018.1466781 · Cited by 74
Emerging perspectives on mitochondrial dysfunction and inflammation in Alzheimer’s disease
Yoo, S., Park, J., Kim, S., & Jung, Y. (2020) · BMB Reports · doi:10.5483/bmbrep.2020.53.1.274 · Cited by 65
Korábečný, J., Nepovimová, E., Cikánková, T., Špilovská, K., Vašková, L., Mezeiová, E., Kuča, K., & Hroudová, J. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2017.06.034 · Cited by 64
Alzheimer’s disease: biological aspects, therapeutic perspectives and diagnostic tools
Carlo, M. D., Giacomazza, D., & Biagio, P. L. S. (2012) · Journal of Physics Condensed Matter · doi:10.1088/0953-8984/24/24/244102 · Cited by 78
Mitochondrial Importance in Alzheimer’s, Huntington’s and Parkinson’s Diseases
Correia, S. C., Santos, R. X., Perry, G. L., Zhu, X., Moreira, P. I., & Smith, M. A. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0653-2_16 · Cited by 73
Koo, J. H., Kwon, I. S., Kang, E. B., Lee, C. K., Lee, N. H., Kwon, M. G., Cho, I. H., & Cho, J. Y. (2013) · Journal of Exercise Nutrition and Biochemistry · doi:10.5717/jenb.2013.17.4.151 · Cited by 66
Antequera, D., Vargas, T., Ugalde, C., Spuch, C., Molina, J. A., Ferrer, I., Bermejo-Pareja, F., & Carro, E. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.06.018 · Cited by 64
RetractedStructure and epimerase activity of anthocyanidin reductase fromVitis vinifera
Gargouri, M., Manigand, C., Mauge, C., Granier, T., d’Estaintot, B. L., Cala, O., Pianet, I., Bathany, K., Chaudière, J., & Gallois, B. (2009) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909025013 · Cited by 76
Amyloid-Binding Alcohol Dehydrogenase (ABAD) Inhibitors for the Treatment of Alzheimer’s Disease
Morsy, A., & Trippier, P. C. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01530 · Cited by 70
Obesity and Diabetes Mediated Chronic Inflammation: A Potential Biomarker in Alzheimer’s Disease
Khan, M. S. H., & Hegde, V. K. (2020) · Journal of Personalized Medicine · doi:10.3390/jpm10020042 · Cited by 75
Diammonium Glycyrrhizinate Upregulates PGC-1α and Protects against Aβ1–42-Induced Neurotoxicity
Zhu, X., Chen, C., Ye, D., Guan, D., Ye, L., Jin, J., Zhao, H., Chen, Y., Wang, Z., Wang, X., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035823 · Cited by 67
Fišar, Z., Hansíková, H., Křížová, J., Jirák, R., Kitzlerová, E., Zvěřová, M., Hroudová, J., Wenchich, L., Zeman, J., & Raboch, J. (2019) · Mitochondrion · doi:10.1016/j.mito.2019.07.013 · Cited by 75
Human ClpP protease, a promising therapy target for diseases of mitochondrial dysfunction
Luo, B., Ma, Y., Zhou, Y., Zhang, N., & Luo, Y. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.01.007 · Cited by 63
Mitochondria Transfer in Brain Injury and Disease
Fairley, L. H., Grimm, A., & Eckert, A. (2022) · Cells · doi:10.3390/cells11223603 · Cited by 71
Xi, Y., Zhang, Y., Zhou, Y., Liu, Q., Chen, X., Liu, X., Grune, T., Shi, L. S., Hou, M., & Liu, Z. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102595 · Cited by 65
Self-citationForet, M. K., Orciani, C., Welikovitch, L. A., Huang, C., Cuello, A. C., & Carmo, S. D. (2024) · Communications Biology · doi:10.1038/s42003-024-06552-4 · Cited by 66
Charge Dependent Retardation of Amyloid β Aggregation by Hydrophilic Proteins
Assarsson, A., Hellstrand, E., Cabaleiro-Lago, C., & Linse, S. S. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn400124r · Cited by 67
Calkins, M. J., & Reddy, P. H. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.04.006 · Cited by 62
Gan, X., Wu, L., Huang, S., Zhong, C., Shi, H., Li, G., Yu, H., Howard Swerdlow, R., Xi Chen, J., & Yan, S. S. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.07.021 · Cited by 62
Self-citationZhang, Y., Xing, S., Zhang, J., Li, J., Li, C., Pei, Z., & Zeng, J. (2010) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2010.127 · Cited by 69
Hroch, L., Guest, P. N., Benek, O., Soukup, O., Janočková, J., Doležal, R., Kuča, K., Aitken, L., Smith, T., Gunn‐Moore, F. J., et al. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.12.029 · Cited by 65
Self-citationSenescence as an Amyloid Cascade: The Amyloid Senescence Hypothesis
Walton, C. C., Begelman, D., Nguyen, W., & Andersen, J. K. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00129 · Cited by 62
Rivière, C., Delaunay, J.-C., Immel, F., Cullin, C., & Monti, J. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9883-6 · Cited by 64
Mutations that affect mitochondrial functions and their association with neurodegenerative diseases
Dhillon, V. S., & Fenech, M. F. (2013) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2013.09.001 · Cited by 63
Catalytic Antioxidants and Neurodegeneration
Golden, T. R., & Patel, M. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2008.2256 · Cited by 65
Wang, H., Xu, X., Pan, Y., Yan, Y., Hu, X., Chen, R., Ravoo, B. J., Guo, D., & Zhang, T. (2020) · Advanced Materials · doi:10.1002/adma.202006483 · Cited by 65
Mitochondrial Permeability Transition: A Pore Intertwines Brain Aging and Alzheimer’s Disease
Jia, K., & Du, H. (2021) · Cells · doi:10.3390/cells10030649 · Cited by 65
Abuelezz, N. Z., Nasr, F. E., AbdulKader, M. A., Bassiouny, A. R., & Zaky, A. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.743573 · Cited by 59
Molecular Basis of Substrate Recognition and Degradation by Human Presequence Protease
King, J. V. L., Liang, W. G., Scherpelz, K. P., Schilling, A. B., Meredith, S. C., & Tang, W. (2014) · Structure · doi:10.1016/j.str.2014.05.003 · Cited by 62
Fiala, J. C., Feinberg, M. D., Peters, A., & Barbas, H. (2007) · Brain Structure and Function · doi:10.1007/s00429-007-0153-1 · Cited by 72
Picone, P., Nuzzo, D., & Carlo, M. D. (2013) · Biological Bulletin · doi:10.1086/bblv224n1p18 · Cited by 65
Coniferaldehyde attenuates Alzheimer's pathology via activation of Nrf2 and its targets
Dong, Y., Stewart, T., Bai, L., Li, X., Xu, T., Iliff, J. J., Shi, M. Y., Zheng, D., Yuan, L., Wei, T., et al. (2019) · Theranostics · doi:10.7150/thno.36722 · Cited by 63
Gender and age-dependent differences in the mitochondrial apoptogenic pathway in Alzheimer's disease
Lloret, A., Badía, M.-C., Mora, N. J., Ortega, Á., Pallardó, F. V., Alonso, M.-D., Atamna, H., & Viña, J. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.02.017 · Cited by 69
Emerging biophysical origins and pathogenic implications of amyloid oligomers
Tang, H., Andrikopoulos, N., Li, Y., Ke, S., Sun, Y., Ding, F., & Ke, P. C. (2025) · Nature Communications · doi:10.1038/s41467-025-58335-y · Cited by 72
Rethinking Alzheimer's Disease Therapy: Are Mitochondria the Key?
Ankarcrona, M., Mangialasche, F., & Winblad, B. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-100327 · Cited by 59
Molecular docking of fisetin with AD associated AChE, ABAD and BACE1 proteins
Dash, R., Emran, T. B., Uddin, M. M. N., Islam, A., & Junaid, M. (2014) · Bioinformation · doi:10.6026/97320630010562 · Cited by 61
Rosales-Corral, S., Acuna-Castroviejo, D., Tan, D. X., López-Armas, G., Cruz-Ramos, J., Munoz, R., Melnikov, V. G., Manchester, L. C., & Reiter, R. J. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/843649 · Cited by 62
Superoxide Anion, Uncoupling Proteins and Alzheimer’s Disease
Wu, Z., Zhao, Y., & Zhao, B. (2010) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.09-104-2 · Cited by 64
Lauritzen, K. H., Moldestad, O., Eide, L., Carlsen, H., Nesse, G., Storm, J. F., Mansuy, I. M., Bergersen, L. H., & Klungland, A. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.01149-09 · Cited by 60
Yu, Q., Wang, Y., Du, F., Yan, S., Hu, G., Origlia, N., Rutigliano, G., Sun, Q., Yu, H., Ainge, J. A., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04389-0 · Cited by 61
Self-citationIijima, K., & Iijima‐Ando, K. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-15402 · Cited by 73
Song, Z., Xie, X., Chen, Y., Zhang, B., Li, X., Yang, Y., Mo, W., Zhang, J., & Xu, D. (2025) · Immunity · doi:10.1016/j.immuni.2025.07.024 · Cited by 67
Liu, D., Xu, Y., Yu, F., Liu, H., Shen, X., Chen, K., Ma, J., & Jiang, H. (2006) · Biochemistry · doi:10.1021/bi060955f · Cited by 63
Somatostatin in Alzheimer's disease: A new Role for an Old Player
Solarski, M., Wang, H., Wille, H., & Schmitt-Ulms, G. (2018) · Prion · doi:10.1080/19336896.2017.1405207 · Cited by 62
Nuclear and mitochondrial DNA oxidation in Alzheimer's disease
Santos, R. X., Correia, S. C., Zhu, X., Lee, H.-G., Petersen, R. B., Nunomura, A., Smith, M. A., Perry, G., & Moreira, P. I. (2012) · Free Radical Research · doi:10.3109/10715762.2011.648188 · Cited by 57
Kumar, S., Henning-Knechtel, A., Magzoub, M., & Hamilton, A. D. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.7b13401 · Cited by 59
Progress in Target Drug Molecules for Alzheimer's Disease
Xie, J., Liang, R., Wang, Y., Huang, J., Cao, X., & Niu, B. (2019) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026619666191203113745 · Cited by 60
Rhein, V., & Eckert, A. (2007) · Archives of Physiology and Biochemistry · doi:10.1080/13813450701572288 · Cited by 56
Neurodegeneration and Alzheimer’s disease: the lesson from tauopathies
Sorrentino, G., & Bonavita, V. (2007) · Neurological Sciences · doi:10.1007/s10072-007-0789-x · Cited by 66
Mitochondrial Dysfunction and Stress Responses in Alzheimer’s Disease
Weidling, I., & Swerdlow, R. H. (2019) · Biology · doi:10.3390/biology8020039 · Cited by 58
Mitochondrial Cascade Hypothesis of Alzheimer's Disease: Myth or Reality?
Mancuso, M., Coppedè, F., Murri, L., & Siciliano, G. (2007) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1761 · Cited by 56
Identification of Human ABAD Inhibitors for Rescuing Aβ-Mediated Mitochondrial Dysfunction
Valaasani, K., Sun, Q., Hu, G., Li, J., Du, F., Guo, Y., Carlson, E., Gan, X., & Yan, S. (2014) · Current Alzheimer Research · doi:10.2174/1567205011666140130150108 · Cited by 53
Self-citationYan, S., Du, F., Wu, L., Zhang, Z., Zhong, C., Yu, Q., Wang, Y., Lue, L., Walker, D. G., Douglas, J. T., et al. (2016) · Diabetes · doi:10.2337/db16-0556 · Cited by 57
Self-citationYang, L., Ye, C.-Y., Huang, X., Tang, X.-C., & Zhang, H. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120274 · Cited by 57
Alikhani, N., Ankarcrona, M., & Glaser, E. G. (2009) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-009-9244-4 · Cited by 57
The role of mitochondrial dysfunction in Alzheimer's disease: A potential pathway to treatment
Reiss, A. B., Ahmed, S., Dayaramani, C., Glass, A. D., Gomolin, I. H., Pinkhasov, A., Stecker, M. M., Wısnıewskı, T., & Leon, J. D. (2022) · Experimental Gerontology · doi:10.1016/j.exger.2022.111828 · Cited by 58
Ding, M., Ding, S., Du, D., Wang, X., Hu, X., Guan, P., Lyu, Z., & Lin, Y. (2023) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2023.117087 · Cited by 59
Amyloid beta receptors responsible for neurotoxicity and cellular defects in Alzheimer’s disease
Kam, T., Gwon, Y., & Jung, Y. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1706-0 · Cited by 64
Amyloid-β peptide-induced cytotoxicity and mitochondrial dysfunction in yeast
Chen, X., & Petranović, D. (2015) · FEMS Yeast Research · doi:10.1093/femsyr/fov061 · Cited by 62
Self-citationHernández-Zimbrón, L. F., & Rivas-Arancibia, S. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.07.011 · Cited by 61
The biological foundation of the genetic association of TOMM40 with late-onset Alzheimer's disease
Zeitlow, K., Charlambous, L., Ng, I., Gagrani, S., Mihovilovic, M., Luo, S., Rock, D. L., Saunders, A., Roses, A. D., & Gottschalk, W. K. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.07.031 · Cited by 54
Berberine Alleviates Amyloid β-Induced Mitochondrial Dysfunction and Synaptic Loss
Zhao, C., Su, P., Lv, C., Guo, L., Cao, G., Qin, C., & Zhang, W. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/7593608 · Cited by 63
Fernandes, T., Resende, R., Silva, D. F., Marques, A. P., Santos, A. E., Cardoso, S. M., Domingues, M. R., Moreira, P. I., & Pereira, C. (2021) · Biomedicines · doi:10.3390/biomedicines9080881 · Cited by 59
Metadata
- Authors
- Lustbader, J. W., Cirilli, M., Lin, C., Xu, H. W., Takuma, K., Wang, N., Caspersen, C., Chen, X., Pollak, S., Chaney, M., Trinchese, F., Liu, S., Gunn-Moore, F., Lue, L.-F., Walker, D. G., Kuppusamy, P., Zewier, Z. L., Arancio, O., Stern, D., Yan, S. S., & Wu, H.
- Affiliations
- Harbin Medical University (CN)
- Center for Reproductive Sciences and Department of Obstetrics and Gynecology, College of Physicians and Surgeons, Columbia University, 630 West 168th Street, New York, NY 10032, USA.
- Corresponding author
- Lustbader, Joyce W.
- Cirilli, Maurizio
- Lin, Chang
- Takuma, Kazuhiro
- Wang, Ning
- Yan, Shirley ShiDu
- Wu, Hao
- ORCID
- Venue
- Science
- Published
- 2004-04-16
- Volume
- 304
- Issue
- 5669
- Pages
- 448-452
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2163757074
- Cited by
- 1,303
- References
- 22
- Citations by year
- 2026: 35 · 2025: 39 · 2024: 43 · 2023: 51 · 2022: 53 · 2021: 64 · 2020: 73 · 2019: 63 · 2018: 61 · 2017: 55 · 2016: 71 · 2015: 42 · 2014: 62 · 2013: 59 · 2012: 76
- FWCI
- 38.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (AG-17490, AG 16736, K07AG000959, P50AG008702, P01AG017490, R01AG016736)
- National Institute of Neurological Disorders and Stroke (NS 42855, R01NS042855)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, amyloid-beta, alcohol dehydrogenase, mitochondrial toxicity, mitochondrial dysfunction, NAD+ binding, protein-protein interaction, oxidative stress, neuronal apoptosis, free radicals, memory impairment, therapeutic target
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Amino Acid Sequence, Animals, Binding Sites, Brain, Brain Chemistry, Carrier Proteins, Cells, Cultured, Cerebral Cortex, Crystallization, Hippocampus, Humans, Learning, Memory, Mice, Transgenic, Mitochondria, Models, Molecular, Molecular Sequence Data, Mutation, NAD, Neurons, Protein Binding, Protein Conformation, 3-Hydroxyacyl CoA Dehydrogenases, Amyloid beta-Peptides, Microscopy, Immunoelectron, Reactive Oxygen Species, Microscopy, Confocal, Mice, DNA Fragmentation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.